首页> 外国专利> The concentration of -25-hydroxyvitamin D3 once a week was kappa alpha_alpha_.

The concentration of -25-hydroxyvitamin D3 once a week was kappa alpha_alpha_.

机译:每周一次的-25-羟基维生素D3浓度为kappa alpha_alpha_。

摘要

A synthetic method for oral or single-dose injection including a 25-hydroxyvitamin D3 sufficient to increase E A man in a pi_delta_serum concentration to a scale of 30 nanograms/ml to 200 nanograms/ml phi__at least 7 days and a suitable carrier system,In a subsequent single dose, at least every 7 days, enough to protect one person at a level of serum concentration, while in scale. 30 ng / ml to 200 ng / ml of pharmacokinetics - in a stable situation.A blood concentration level increases and the retention of 25 hydroxyvitamin D3 is needed in humans. The composition of the injection or the injection.A serum level of 25-_delta_Zeta Zeta_-vitamin D3 is required for this person who may be vitamin D deficient less than 30 nanograms/ml.
机译:一种用于口服或单剂量注射的合成方法,包括至少7天足以使pidelta_serum浓度增加到30纳克/毫升至200纳克/毫升ph值的水平的25-羟基维生素D3和合适的载体系统,在随后的单次剂量中(至少每7天一次)足以在规模上以一个血清浓度水平保护一个人。 30 ng / ml至200 ng / ml的药代动力学-在稳定的情况下。血液中的血药浓度升高,人体中需要保留25个羟基维生素D3。注射剂或注射剂的组成。此人可能是维生素D缺乏症低于30纳克/毫升的人,其血清水平为25-δ_Zeta-维生素D3。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号